| Q46448797 | A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients |
| Q34309884 | An economic overview of chronic obstructive pulmonary disease |
| Q43043371 | Assessment of quality of life in lung transplantation using a simple generic tool |
| Q80308308 | Cost analysis of home monitoring in lung transplant recipients |
| Q35610416 | Cost effectiveness of lung volume reduction surgery |
| Q40547133 | Economic considerations and future directions for lung volume reduction surgery |
| Q48551397 | Factors affecting attainment of paid employment after lung transplantation |
| Q34803014 | Pharmaco-economics of blood transfusion safety: review of the available evidence |
| Q35894922 | Quality of life after lung transplantation |
| Q37061393 | Technology and outcomes assessment in lung transplantation |
| Q52242356 | Technology assessment of the Dutch Lung Transplantation Program. |
| Q43819597 | The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program. |
| Q34770001 | Worldwide guidelines for chronic obstructive pulmonary disease: a comparison of diagnosis and treatment recommendations |